(Q24242965)

https://api.crossref.org/works/10.1002%2F14651858.CD004413.PUB2

Topical minoxidil in alopecia areata: no effect on the perifollicular lymphoid infiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004413.PUB2

Efficacy of betamethasone valerate foam formulation in comparison with betamethasone dipropionate lotion in the treatment of mild-to-moderate alopecia areata: a multicenter, prospective, randomized, controlled, investigator-blinded trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004413.PUB2

Lack of efficacy of topical latanoprost in the treatment of eyebrow alopecia areata

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004413.PUB2

Evidence-based treatment of alopecia areata

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004413.PUB2

Concepts of patients with alopecia areata about their disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004413.PUB2

When are randomised trials unnecessary? Picking signal from noise

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004413.PUB2

Genetics of alopecia areata.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004413.PUB2

Systematic reviews in health care: Assessing the quality of controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004413.PUB2

Guidelines for the management of alopecia areata

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004413.PUB2

21 January 2018

Alopecia areata update

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004413.PUB2

Induction of hair growth in alopecia totalis with diphencyprone sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004413.PUB2

Therapy of Alopecia Areata: On the Cusp and in the Future

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004413.PUB2

Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004413.PUB2

Strategies of coping and quality of life in women with alopecia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004413.PUB2

Randomized trial of aromatherapy. Successful treatment for alopecia areata

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004413.PUB2

7 January 2021

Randomized double-blind placebo-controlled trial in the treatment of alopecia areata with 0.25% desoximetasone cream

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004413.PUB2

7 January 2021

Alopecia areata during treatment with biologic agents

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004413.PUB2

7 January 2021

Development of alopecia areata universalis in a patient receiving adalimumab

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004413.PUB2

7 January 2021

ALOPECIA AREATA. AN EVALUATION OF 736 PATIENTS

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004413.PUB2

7 January 2021

Topical treatment of alopecia areata

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004413.PUB2

7 January 2021

Topical minoxidil lacks efficacy in alopecia areata

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004413.PUB2

7 January 2021

Topical minoxidil in the treatment of alopecia areata and male-pattern alopecia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004413.PUB2

7 January 2021

Alopecia totalis: is treating nonresponder patients useful?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004413.PUB2

7 January 2021

Treatment of chronic severe alopecia areata with topical diphenylcyclopropenone and 5% minoxidil: a clinical and immunopathologic evaluation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004413.PUB2

7 January 2021

Alopecia areata investigational assessment guidelines--Part II. National Alopecia Areata Foundation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004413.PUB2

7 January 2021

Therapies versus placebo in the treatment of patchy alopecia areata.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004413.PUB2

7 January 2021

Topical minoxidil (3%) in extensive alopecia areata, including long-term efficacy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004413.PUB2

7 January 2021

A randomized double-blind study of inosiplex (isoprinosine) therapy in patients with alopecia totalis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004413.PUB2

7 January 2021

Therapy versus placebo for alopecia areata

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004413.PUB2

7 January 2021

Treatment of severe alopecia areata with topical diphenylcyclopropenone and 5% minoxidil: a clinical and immunopathologic evaluation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004413.PUB2

7 January 2021

The genetic basis of alopecia areata: HLA associations with patchy alopecia areata versus alopecia totalis and alopecia universalis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004413.PUB2

7 January 2021

The new biologics in psoriasis: possible treatments for alopecia areata

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004413.PUB2

7 January 2021

Topical photodynamic therapy with 5-aminolaevulinic acid does not induce hair regrowth in patients with extensive alopecia areata

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004413.PUB2

7 January 2021

Treatment of alopecia totalis with a combination of inosine pranobex and diphencyprone compared to each treatment alone

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004413.PUB2

7 January 2021

Topical minoxidil in the treatment of alopecia areata.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004413.PUB2

7 January 2021

Topical minoxidil in extensive alopecia areata, including 3-year follow-up

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004413.PUB2

7 January 2021

Imipramine in alopecia areata. A double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004413.PUB2

7 January 2021